Taro Pharmaceutical Industries LtdNYSE:TARO
- LAST PRICE42.1600
- TODAY'S CHANGE (%)-0.0700 (-0.1658%)
- Bid / Lots42.1600/ 1
- Ask / Lots42.2100/ 1
- Open / Previous Close42.1500 / 42.2300
- Day Range
- 52 Week Range
- Volume3,667
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | TARO |
|---|---|---|
| 09:32 ET | 325 | 42.17 |
| 09:34 ET | 223 | 42.14 |
| 10:26 ET | 200 | 42.225 |
| 10:33 ET | 100 | 42.19 |
| 10:35 ET | 100 | 42.19 |
| 10:37 ET | 100 | 42.2 |
| 10:53 ET | 100 | 42.2 |
| 11:40 ET | 100 | 42.18 |
| 11:56 ET | 883 | 42.16 |
Yesterday
Apr 22, 2024
TARO PHARMACEUTICAL INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Taro Pharmaceutical Industries Ltd. - TARO, from 4:06PM ET on Monday Apr 22, 2024 by Dow Jones
4:06PM ET on Monday Apr 22, 2024 by Dow Jones
Apr 15, 2024
Taro Announces Extraordinary General Meeting and Ordinary Class Meeting of Shareholders for Approval of Merger with Sun Pharmaceutical Industries Ltd., from 8:00AM ET on Monday Apr 15, 2024 by Dow Jones
8:00AM ET on Monday Apr 15, 2024 by Dow Jones*DJ Taro Announces Extraordinary General Meeting And Ordinary Class Meeting Of Shareholders For Approval Of Merger With Sun Pharmaceutical Industries Ltd. >TARO, from 8:00AM ET on Monday Apr 15, 2024 by Dow Jones
8:00AM ET on Monday Apr 15, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Taro Pharmaceutical Industries Ltd | 1.6B | 34.7x | -33.66% |
Harmony Biosciences Holdings Inc | 1.6B | 13.6x | --- |
Collegium Pharmaceutical Inc | 1.2B | 40.2x | --- |
Tilray Brands Inc | 1.4B | -3.6x | --- |
ANI Pharmaceuticals Inc | 1.4B | 80.4x | -8.16% |
Amphastar Pharmaceuticals Inc | 2.0B | 15.9x | --- |
Company Information
Taro Pharmaceutical Industries Ltd. (Taro) is a science-based pharmaceutical company. The Company operates principally through three entities: Taro Pharmaceutical Industries Ltd. (Taro Israel), and two of its subsidiaries, Taro Pharmaceuticals Inc. (Taro Canada) and Taro U.S.A. The Company markets over 200 pharmaceutical products in over 25 countries. The Company's owned product brands include Rokacet, with generic names, such as acetaminophen, codeine and caffeine; Topicort, with the generic name, desoximetasone; Etopan, with the generic name etodolac, and Ovide, with the generic name, malathion, among others. The Company's other generic products include acetazolamide, adapalene, alclometasone dipropionate, amiodarone hydrochloride, ammonium lactate, augmented betamethasone dipropionate, cetirizine hydrochloride, clobetasol propionate, clomipramine hydrochloride, clorazepate dipotassium, fluorouracil, ketoconazole, metronidazole, mupirocin and warfarin sodium, among others.
Contact Information
- Headquarters
- 14 Hakitor Street, PO Box 10347HAIFA, Israel 2624761
- Phone
- ---
- Fax
- ---
Executives
- Chairman of the Board
- Dilip Shanghvi
- Chief Executive Officer, Director
- Uday Baldota
- Vice Chairman of the Board
- Abhay Gandhi
- Chief Financial Officer, Chief Accounting Officer, Vice President
- William Coote
- Director
- Oded Sarig
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $1.6B |
|---|---|
Revenue (TTM) | $610.8M |
Shares Outstanding | 37.6M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 0.60 |
EPS | $1.22 |
Book Value | $46.05 |
P/E Ratio | 34.7x |
Price/Sales (TTM) | 2.6 |
Price/Cash Flow (TTM) | 20.0x |
Operating Margin | 3.60% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
